P512: A PHASE 1B/2 STUDY OF TP-0903 AND DECITABINE TARGETING MUTANT TP53 AND/OR COMPLEX KARYOTYPE IN PATIENTS WITH UNTREATED ACUTE MYELOID LEUKEMIA (AML) ≥ AGE 60 YEARS: FINAL RESULTS

• Alice Mims,
• Ying Huang,
• Eric Eisenmann,
• Shelley Orwick,
• Daelynn Buelow,
• Ronan Swords,
• Joshua Zeidner,
• Matthew Foster,
• Tara L. Lin,
• Maria Baer,
• Yazan Madanat,
• Tibor Kovacsovics,
• Robert Redner,
• Zeina Al-Mansour,
• Mona Stefanos,
• Molly Martycz,
• Franchesca Druggan,
• Timothy Chen,
• Ashley Yocum,
• Uma Borate,
• Brian Druker,
• Amy Burd,
• Ross Levine,
• Sharyn Baker,
• John C. Byrd

Affiliations

Alice Mims

1 The Ohio State University, Columbus, United States

Ying Huang

1 The Ohio State University, Columbus, United States

Eric Eisenmann

1 The Ohio State University, Columbus, United States

Shelley Orwick

1 The Ohio State University, Columbus, United States

Daelynn Buelow

1 The Ohio State University, Columbus, United States

Ronan Swords

2 Oregon Health and Science University, Portland, United States

Joshua Zeidner

3 University of North Carolina at Chapel Hill, Chapel Hill, United States

Matthew Foster

3 University of North Carolina at Chapel Hill, Chapel Hill, United States

Tara L. Lin

4 University of Kansas, Kansas City, United States

Maria Baer

5 University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, United States

Yazan Madanat

6 UT Southwestern Medical Center, Dallas, United States

Tibor Kovacsovics

7 The University of Utah, Salt Lake City, United States

Robert Redner

8 University of Pittsburgh, Pittsburgh, United States

Zeina Al-Mansour

9 University of Florida, Gainesville, United States

Mona Stefanos

10 The Ohio State University, Columbus, United States

Molly Martycz

10 The Ohio State University, Columbus, United States

Franchesca Druggan

10 The Ohio State University, Columbus, United States

Timothy Chen

1 The Ohio State University, Columbus, United States

Ashley Yocum

11 The Leukemia & Lymphoma Society, Rye Brook, United States

Uma Borate

10 The Ohio State University, Columbus, United States

Brian Druker

2 Oregon Health and Science University, Portland, United States

Amy Burd

11 The Leukemia & Lymphoma Society, Rye Brook, United States

Ross Levine

12 Memorial Sloan Kettering Cancer Center, New York, United States

Sharyn Baker

10 The Ohio State University, Columbus, United States

John C. Byrd

13 University of Cincinnati, Cincinnati, United States